AR040651A1 - Polipeptido t20 pegilado - Google Patents

Polipeptido t20 pegilado

Info

Publication number
AR040651A1
AR040651A1 AR20030102621A ARP030102621A AR040651A1 AR 040651 A1 AR040651 A1 AR 040651A1 AR 20030102621 A AR20030102621 A AR 20030102621A AR P030102621 A ARP030102621 A AR P030102621A AR 040651 A1 AR040651 A1 AR 040651A1
Authority
AR
Argentina
Prior art keywords
polypeptide
compounds
nht20
succinimidyloxy
ch2ch2
Prior art date
Application number
AR20030102621A
Other languages
English (en)
Inventor
Chee-Youb Won
Pascal Sebastian Bailon
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR040651A1 publication Critical patent/AR040651A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16HIV-1 ; HIV-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan compuestos polipéptidos T20 pegilados. También se proporcionan composiciones farmacéuticas que contienen compuestos polipéptidos T20 pegilados, y proceso de elaboración y uso de tales compuestos y composiciones. Reivindicación 1: Un compuesto de fórmula: R1-(CH2CHO)n-CH2CH2-O-(CH2)m-C(O)-NH-(CH2)p-CH2-NHT20 en donde: R1 es un grupo de cabeza, m es de 1 a 17, n es de 10 a 1.000, p es de 1 a 3, y NHT20 es un polipéptido T20 unido covalentemente a través de su grupo alfa-amino terminal. Reivindicación 2: Un compuesto de acuerdo con la reivindicación 1, en donde R1 se selecciona del grupo consistente de halógeno, epóxido, maleimida, disulfuro de ortopiridilo, tosilato, isocianato, hidrato de hidrazina, haluro cianúrico, N-succinimidiloxi, sulfo-N-succinimidiloxi, 1-benzotriazoliloxi, 1-imidazoliloxi, p-nitrofeniloxi, y -CH2CH2-O-(CH2)m-C(O)-NH-(CH2)p-CHO.
AR20030102621A 2002-07-24 2003-07-22 Polipeptido t20 pegilado AR040651A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39819502P 2002-07-24 2002-07-24

Publications (1)

Publication Number Publication Date
AR040651A1 true AR040651A1 (es) 2005-04-13

Family

ID=31495720

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20030102621A AR040651A1 (es) 2002-07-24 2003-07-22 Polipeptido t20 pegilado

Country Status (24)

Country Link
US (1) US7049415B2 (es)
EP (1) EP1527088B1 (es)
JP (1) JP4381301B2 (es)
KR (1) KR100637981B1 (es)
CN (1) CN100357317C (es)
AR (1) AR040651A1 (es)
AT (1) ATE489401T1 (es)
AU (1) AU2003257467B2 (es)
BR (1) BR0312889A (es)
CA (1) CA2493534C (es)
DE (1) DE60335111D1 (es)
ES (1) ES2354609T3 (es)
GT (1) GT200300155A (es)
HR (1) HRP20050024A2 (es)
IL (2) IL166038A0 (es)
MX (1) MXPA05000797A (es)
NO (1) NO20050066L (es)
PA (1) PA8577701A1 (es)
PE (1) PE20040705A1 (es)
PL (1) PL375254A1 (es)
RU (1) RU2296769C2 (es)
TW (1) TW200416225A (es)
WO (1) WO2004013164A1 (es)
ZA (1) ZA200500258B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
EP2298278B1 (en) 2002-06-07 2015-11-11 Dyax Corp. Prevention and reduction of blood loss and inflammatory response
JP2007504169A (ja) * 2003-08-29 2007-03-01 ダイアックス コーポレーション 修飾されたプロテアーゼインヒビター
PT1663281E (pt) * 2003-08-29 2014-03-17 Dyax Corp Inibidores de proteases poli-peguilados
AU2005222641B2 (en) * 2004-03-15 2011-04-07 Nektar Therapeutics Polymer-based compositions and conjugates of HIV entry inhibitors
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
ES2336245T3 (es) * 2005-04-08 2010-04-09 Lonza Ag Sintesis peptidica de helices alfa sobre resina de peg.
CA2696208A1 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
WO2010080833A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
EP3459564B1 (en) 2010-01-06 2021-10-27 Takeda Pharmaceutical Company Limited Plasma kallikrein binding proteins
KR102169651B1 (ko) 2011-01-06 2020-10-23 다이액스 코포레이션 혈장 칼리크레인 결합 단백질
IL247942B (en) 2014-03-27 2022-09-01 Dyax Corp Compositions and methods for drops in macular edema as a result of diabetes
US10046058B2 (en) 2014-12-02 2018-08-14 Rezolute, Inc. Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates
IL311156A (en) 2015-12-11 2024-04-01 Takeda Pharmaceuticals Co Plasma kallikrein inhibitors and their uses in the treatment of hereditary angioedema attack

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US153694A (en) * 1874-08-04 Improvement in clothes-pounders
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
CH690143A5 (de) * 1995-01-27 2000-05-15 Rieter Automotive Int Ag Lambda/4-Schallabsorber.
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
JP4602547B2 (ja) * 1998-03-23 2010-12-22 トリメリス,インコーポレーテッド ペプチド合成のための方法および組成物
AU2346900A (en) * 1998-11-30 2000-06-19 Eli Lilly And Company Erythropoietic compounds
PE20010288A1 (es) * 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
KR100488351B1 (ko) * 2001-12-11 2005-05-11 선바이오(주) 신규한 폴리에틸렌글리콜-프로피온알데히드 유도체

Also Published As

Publication number Publication date
HRP20050024A2 (en) 2006-02-28
NO20050066L (no) 2005-04-22
BR0312889A (pt) 2005-06-14
IL166038A0 (en) 2006-01-15
AU2003257467A1 (en) 2004-02-23
KR100637981B1 (ko) 2006-10-23
JP2006511455A (ja) 2006-04-06
WO2004013164A1 (en) 2004-02-12
EP1527088B1 (en) 2010-11-24
RU2296769C2 (ru) 2007-04-10
RU2005105577A (ru) 2005-10-27
TW200416225A (en) 2004-09-01
EP1527088A1 (en) 2005-05-04
DE60335111D1 (de) 2011-01-05
AU2003257467B2 (en) 2008-02-28
MXPA05000797A (es) 2005-04-19
KR20050027257A (ko) 2005-03-18
CA2493534C (en) 2010-01-26
PE20040705A1 (es) 2004-10-14
IL166038A (en) 2010-11-30
JP4381301B2 (ja) 2009-12-09
GT200300155A (es) 2004-03-15
CN100357317C (zh) 2007-12-26
PA8577701A1 (es) 2004-02-07
CA2493534A1 (en) 2004-02-12
CN1671736A (zh) 2005-09-21
PL375254A1 (en) 2005-11-28
ZA200500258B (en) 2006-01-25
US7049415B2 (en) 2006-05-23
ES2354609T3 (es) 2011-03-16
US20040049018A1 (en) 2004-03-11
ATE489401T1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
AR040651A1 (es) Polipeptido t20 pegilado
ATE47137T1 (de) Verfahren zur herstellung von taxol und von desazetyl-10-taxol.
RU2006103988A (ru) Политиоэфиры с концевой эпоксигруппой
IL98933A0 (en) Benzimidazoles,their preparation and pharmaceutical compositions containing them
EP0125826A2 (en) Fluoroaliphatic sulfonamides containing oxirane groups and/or N-B-hydroxyalkylene groups
FR2286129A1 (fr) Procede de production d'esters aromatiques d'acide cyanique particulierement purs
Mantecon et al. Curing of N, N′-diglycidylimides with polyfunctional compounds
KR970704712A (ko) 카복실화된 아미노-1,3,5-트리아진 및 이의 유도체의 제조 방법(process for the preparation of carboxylated amino-1,3,5-triazines and derivatives thereof)
DE60117866D1 (de) Zweikomponentige chemische befestigungssysteme
ATE24528T1 (de) Verfahren zur herstellung von verbundfolien.
ATE294827T1 (de) Addukte von polyalkylenglykolmonoglycidylethern und aminverbindungen
GB1119306A (en) Organic substituted sulphonyl diamides and their use in hardening gelatine
CA2046139A1 (en) Bis-oxazolidines, oxazolidine mixtures consisting essentially thereof, a process for their production and their use as hardeners for plastics precursors containing isocyanate groups
IL79781A0 (en) Indolinone derivatives,processes for their preparation,medicaments containing them,and their use
DE3162641D1 (en) Polytriazinyl amines, process for their preparation, their use as stabilizing agents for synthetic polymers and polymers stabilized with these compounds
GB1193709A (en) Reaction Products of N-3-Oxohydrocarbon-Substituted Acrylamides with Active Hydrogen Compounds
KR950014169A (ko) 폴리아미노폴리아미드
ATE97941T1 (de) Polyamidharz-zusammensetzung.
RU95110782A (ru) Эластичная композиция на основе эпоксидной смолы и способ ее получения
Groβ et al. Spectroscopical contributions to the regioselectivity of nucleophilic curing reactions in epoxy resins
ES8507589A1 (es) Procedimiento de obtencion de composiciones de poliuretano termoendurecibles
DE50212739D1 (de) Verfahren zur herstellung von isocyanaten
GB1529046A (en) Polyether polyureides
RU92007666A (ru) Уретаносодержащие простые полиэфиры с концевыми первичными аминогруппами в качестве отвердителей эпоксидных смол и эпоксидная композиция на их основе (варианты)
ES2031274T3 (es) Procedimiento de preparacion de diaminas aromaticas con un grupo polidiorganosiloxano.

Legal Events

Date Code Title Description
FB Suspension of granting procedure